Ranked #15 Global Futurist and Top 50 in AI, the Disruptive Futures Institute Chair Bridges Silicon Valley and High ...

As Military Citations Surge, DFI Bridges Boardrooms and Tactical Edges to Navigate the Metaruption Era’s Collision of ...

Disruptive Futures Institute Affirms Metaruptions Concept as Word of the Year, Demonstrating Prescient Framework that ...

Many future-oriented works in governments fail due to very obvious reasons. Much of this work usually lives in a single unit and produces interesting outputs, but is not connected to any policy cycles ...

If you’re walking into the “Universal Theme Parks: The Exhibition” at the Franklin Institute expecting a parade of Minions and Harry Potter photo ops, here’s a little heads up: You need to recalibrate ...

The Country Programme Document (CPD) is the cornerstone of UNDP’s engagement with partner countries, outlining how UNDP will support national priorities and contribute to sustainable development over ...

When Terry Mathis and I wrote Forecasting Tomorrow: The Future of Safety Excellence in 2015, our aim was simple: help leaders stop reacting to yesterday’s incidents and start deliberately designing ...

Natera last week said it completed the acquisition of Foresight Diagnostics, expanding the company’s position in solid tumor molecular residual disease detection, particularly in lymphoma, a cancer of ...

Natera said it has acquired Foresight Diagnostics in a deal valued at up to $450 million, bolstering the company's portfolio of minimal residual disease, or MRD, testing products. The genetic testing ...

Natera is looking to grow its portfolio of tools to detect the recurrence of cancer with a deal to acquire Foresight Diagnostics, the Stanford University spinout and developer of blood tests for ...

BOULDER — An Austin, Texas-based genetics-testing company that specializes in cell-free DNA and precision medicine has acquired Foresight Diagnostics Inc., a Boulder-based cancer-diagnostics company.

AUSTIN, Texas & BOULDER, Colo.--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, and Foresight Diagnostics, a leader in ultrasensitive molecular ...